Stock ABLD ABL DIAGNOSTICS
Add to a list
To use this feature you must be a member
Log inSign up

ABL Diagnostics Stock

Equities

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 05:30:11 2024-07-05 am EDT 		5-day change 1st Jan Change
2.8 EUR 0.00% Intraday chart for ABL Diagnostics 0.00% -71.13%
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Financials

Sales 2024 * 6.3M 6.83M Sales 2025 * 8.52M 9.23M Capitalization 45.12M 48.9M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 7.16 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 5.3 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 21
Yield 2024 *
-
Yield 2025 *
-
Free-Float 0.36%
More Fundamentals * Assessed data

Chart ABL Diagnostics

Dynamic Chart

Latest news about ABL Diagnostics

ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa MT
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons. CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Advanced Biological Laboratories S.A. agreed to acquire the remaining 3.3% stake in Fauvet-Girel for €0.13 million. CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million. CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in Fauvet-Girel from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million. CI
Fauvet-Girel Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Bernard Krief Consultants SA completed the acquisition of 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family. CI
Bernard Krief Consultants SA signed an agreement to acquire 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family for €8.1 million. CI
Fauvet-Girel(ENXTPA:FAUV) dropped from CAC All-Tradable Index CI
Fauvet-Girel(ENXTPA:FAUV) dropped from CAC Small Index CI
More news

Press releases ABL Diagnostics

ABL Diagnostics and Laborama officially appointed to offer NGS genotyping solutions to the National Laboratory for Public Health (NLPH) in Lithuania. AQ
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S. AQ
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA AQ
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain. AQ
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B) AQ
More press releases

News in other languages on ABL Diagnostics

ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ
ABL Diagnostics : annonce l’initiation de couverture de son titre par In Extenso Finance
Un Chiffre d’Affaires en croissance (VIH et hors Covid) et un Résultat Net Comptable positif en 2023 - Le témoignage de la capacité d’ABL Diagnostics à exécuter et à faire avancer ses grands projets stratégiques
ABL Diagnostics annonce l’initiation de couverture de son titre par In Extenso Finance
ABL Diagnostics : Retard dans la publication des comptes annuels 2023
More news

Quotes and Performance

1 month-7.89%
3 months-11.95%
6 months-71.13%
Current year-71.13%
More quotes

Highs and lows

1 week
2.80
Extreme 2.8
2.90
1 month
2.80
Extreme 2.8
3.04
Current year
2.80
Extreme 2.8
9.70
1 year
2.80
Extreme 2.8
9.70
3 years
1.99
Extreme 1.9875
26.00
5 years
1.28
Extreme 1.275
26.00
10 years
1.28
Extreme 1.275
26.00
More quotes

Managers and Directors - ABL Diagnostics

Managers TitleAgeSince
Ronan Boulme CEO
 Chief Executive Officer - -
Members of the board TitleAgeSince
Jean Christophe Renondin BRD
 Director/Board Member - -
Laure Raffaelli BRD
 Director/Board Member - -
Noemie Sadoun CHM
 Chairman - -
More insiders

Quotes

Date Price Change Volume
24-07-05 2.8 0.00% 152
24-07-04 2.8 -3.45% 148
24-07-03 2.9 0.00% 1
24-07-02 2.9 +3.57% 8
24-07-01 2.8 0.00% 1

Real-time Euronext Paris, July 05, 2024 at 05:30 am EDT

More quotes

Company Profile

ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.3% of net sales.
Sector
Medical Equipment, Supplies & Distribution
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.8 EUR
Average target price
6.01 EUR
Spread / Average Target
+114.64%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABL DIAGNOSTICS Stock ABL Diagnostics
-71.13% 48.78M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.50% 178B
MEDTRONIC PLC Stock Medtronic plc
-5.79% 98.95B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.59% 66.14B
DEXCOM, INC. Stock DexCom, Inc.
-8.38% 44.11B
CENCORA, INC. Stock Cencora, Inc.
+8.42% 43.82B
HOYA CORPORATION Stock Hoya Corporation
+10.10% 42.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+10.97% 28.92B
TERUMO CORPORATION Stock Terumo Corporation
+18.89% 25.06B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.39% 23.38B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ABLD Stock